| Cardiac Potassium Channels: Physiological Insights for Targeted Therapy |
8 |
| AHU377+Valsartan (LCZ696) Modulates Renin-Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan |
8 |
| The Role of Peroxisome Proliferator-Activated Receptor in Mediating Cardioprotection Against Ischemia/Reperfusion Injury |
8 |
| Simvastatin Suppresses Interleukin I beta Release in Human Peripheral Blood Mononuclear Cells Stimulated With Cholesterol Crystals |
8 |
| Anticoagulation Therapy in Specific Cardiomyopathies: Isolated Left Ventricular Noncompaction and Peripartum Cardiomyopathy |
7 |
| Does p53 Inhibition Suppress Myocardial Ischemia-Reperfusion Injury? |
7 |
| Effect of Ischemic Postconditioning on Myocardial Function and Infarct Size Following Reperfusion Injury in Diabetic Rats Pretreated With Vildagliptin |
7 |
| Prospects for the Primary Prevention of Myocardial Infarction and Stroke |
6 |
| Role of Platelet Activation and Oxidative Stress in the Evolution of Myocardial Infarction |
6 |
| Cardioprotective Role of Colchicine Against Inflammatory Injury in a Rat Model of Acute Myocardial Infarction |
6 |
| The Utility of Anti-Inflammatory Agents in Cardiovascular Disease: A Novel Perspective on the Treatment of Atherosclerosis |
6 |
| Angiotensin-Converting Enzyme Inhibitors Provide Better Long-Term Survival Benefits to Patients With AMI Than Angiotensin II Receptor Blockers After Survival Hospital Discharge |
5 |
| Temporal Trends in the Use of Antiplatelet Therapy in Patients With Acute Coronary Syndromes |
5 |
| A Review on Potential Involvement of TRPV1 Channels in Ischemia-Reperfusion Injury |
5 |
| Cardiosphere-Derived Cells Attenuate Inflammation, Preserve Systolic Function, and Prevent Adverse Remodeling in Rat Hearts With Experimental Autoimmune Myocarditis |
5 |
| Quality of Life and Its Association With Treatment Satisfaction, Adherence to Medication, and Trust in Physician Among Patients With Hypertension: A Cross-Sectional Designed Study |
5 |
| The Role of Vildagliptin in Treating Hypertension Through Modulating Serum VEGF in Diabetic Hypertensive Patients |
5 |
| Opioids in Cardiovascular Disease: Therapeutic Options |
5 |
| Beneficial Effect of the SGLT2 Inhibitor Empagliflozin on Glucose Homeostasis and Cardiovascular Parameters in the Cohen Rosenthal Diabetic Hypertensive (CRDH) Rat |
5 |
| The Impact of Pazopanib on the Cardiovascular System |
4 |
| Cardioprotective and Anti-Aggregatory Effects of Levosimendan on Isoproterenol-Induced Myocardial Injury in High-Fat-Fed Rats Involves Modulation of PI3K/Akt/mTOR Signaling Pathway and Inhibition of Apoptosis: Comparison to Cilostazol |
4 |
| Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis |
4 |
| Ticagrelor Does Not Protect Isolated Rat Hearts, Thus Clouding Its Proposed Cardioprotective Role Through ENT 1 in Heart Tissue |
4 |
| Adherence to Oral Anticoagulants in Atrial Fibrillation: An Australian Survey |
4 |
| Pharmacogenetics of Warfarin in a Diverse Patient Population |
4 |
| Comparative Effectiveness and Safety Between Milrinone or Dobutamine as Initial Inotrope Therapy in Cardiogenic Shock |
4 |
| Characteristics of Apixaban-Treated Patients, Evaluation of the Dose Prescribed, and the Persistence of Treatment: A Cohort Study in Catalonia |
4 |
| Inhibition of Na+/H+ Exchanger With EMD 87580 does not Confer Greater Cardioprotection Beyond Preconditioning on Ischemia-Reperfusion Injury in Normal Dogs |
3 |
| Effects of Heart Rate Reduction With Either Pyridostigmine or Ivabradine in Patients With Heart Failure: A Randomized, Double-Blind Study |
3 |
| Effects of PCSK9 Inhibitors on Other than Low-Density Lipoprotein Cholesterol Lipid Variables |
3 |
| Cangrelor in Percutaneous Coronary Intervention: Current Status and Perspectives |
3 |
| Sitagliptin Attenuates Endothelial Dysfunction of Zucker Diabetic Fatty Rats: Implication of the Antiperoxynitrite and Autophagy |
3 |
| Exercise and Cardioprotection: A Natural Defense Against Lethal Myocardial Ischemia-Reperfusion Injury and Potential Guide to Cardiovascular Prophylaxis |
3 |
| Does Ticagrelor Improve Endothelial Function? |
3 |
| Testosterone Replacement Therapy in Deficient Patients With Chronic Heart Failure: A Randomized Double-Blind Controlled Pilot Study |
3 |
| Effect of Patiromer in Hyperkalemic Patients Taking and Not Taking RAAS Inhibitors |
3 |
| Regression of Atherosclerotic Plaques of Cholesterol-Fed Rabbits by Combined Chemotherapy With Paclitaxel and Methotrexate Carried in Lipid Core Nanoparticles |
3 |
| Resveratrol Attenuates Cardiomyocyte Apoptosis in Rats Induced by Coronary Microembolization Through SIRT1-Mediated Deacetylation of p53 |
3 |
| Cardiovascular Safety of the Selective -Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation |
3 |
| Involvement of Vitamin K-Dependent Proteins in Vascular Calcification |
3 |
| The Protective Effects of Preconditioning With Dioscin on Myocardial Ischemia/Reperfusion-Induced Ventricular Arrhythmias by Increasing Connexin 43 Expression in Rats |
3 |
| Systematic Review of the Effect of Adherence to Statin Treatment on Critical Cardiovascular Events and Mortality in Primary Prevention |
3 |
| Chrysin Suppresses Vascular Endothelial Inflammation via Inhibiting the NF-kappa B Signaling Pathway |
3 |
| Appropriateness of Dabigatran and Rivaroxaban Prescribing in Qatar: A 5-Year Experience |
3 |
| Cardiorenal Safety of OTC Analgesics |
3 |
| Angiogenic Growth Factors for Coronary Artery Disease: Current Status and Prospects |
2 |
| Impact of Test Conditions on ADP-Induced Platelet Function Results With the Multiplate Assay: Is Further Standardization Required? |
2 |
| Recombinant Human Cytoglobin Prevents Atherosclerosis by Regulating Lipid Metabolism and Oxidative Stress |
2 |
| A New Perspective on the Nitrate-Phosphodiesterase Type 5 Inhibitor Interaction |
2 |
| Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction? |
2 |
